Declarations. Funding: No external funding was used in the preparation of this commentary. Conflict of Interest: Antoine Garnier-Crussard, Virginie Dauphinot, Christelle Mouchoux, and Teddy Novais declare that they have no potential conflicts of interest that might be relevant to the contents of this commentary. Independent of this work, Antoine Garnier-Crussard is an unpaid subinvestigator or local principal investigator for clinical trials and studies sponsored by UCB Pharma, Biogen, TauRx Therapeutics, Roche, Novo Nordisk, Alzheon, Medesis Pharma, and GlaxoSmithKline and received research grants from Roche, Lilly, and Eisai. He declares that he has not received any personal funding and has not participated in any remunerated activities. Ethics Approval: Not applicable. Consent to Participate: Not applicable. Consent for Publication: Not applicable. Data Availability: Data sharing is not applicable to this commentary as no datasets were generated for it. Code Availability: Not applicable. Authors' Contributions: All authors participated in writing and reviewing this commentary.